Direxion Daily Financial Bull 3X Shares ETF
FAS
Direxion Daily Energy Bull 2X Shares ETF
ERX
Ultra Financials Proshares
UYG
4
Invesco DB Commodity Index Tracking Fund
DBC
5
Energy Select Sector SPDR Fund
XLE
US Stock MarketDetailed Quotes
AbCellera Biologics (ABCL)
- 5.335
- +0.025+0.47%
Trading Jul 27 11:20 ET
1.63BMarket Cap-11.11P/E (TTM)
5.500High5.255Low1.40MVolume5.370Open5.310Prev Close7.53MTurnover0.68%Turnover RatioLossP/E (Static)305.38MShares8.44052wk High1.74P/B1.09BFloat Cap2.74552wk Low--Dividend TTM205.09MShs Float71.910Historical High--Div Yield TTM4.61%Range %1.891Historical Low5.396Avg Price1Lot Size
ABCL Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
ABCL Orderflow
Unit: --
ABCL Orderflow Trend
IntradayDayWeekMonth
No Data
AbCellera Biologics (ABCL) News
Insiders Enjoy US$772k Return After Buying AbCellera Biologics Stock
Cantor Fitzgerald Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $11
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), AbCellera Biologics (ABCL) and DBV Technologies SA – American (DBVT)
Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS) and AbCellera Biologics (ABCL)
AbCellera Biologics Stock (ABCL) Opinions on Jazz Partnership and Analyst Upgrade
3 Under-$10 Stocks With Strong Upside to Watch This Week, According to Analysts
AbCellera Biologics (ABCL) Stock Forum
$AbCellera Biologics (ABCL.US)$ $ABCL: The recent headlines aren’t the real story.
Most of the latest news has already been priced in. The earnings date announcement, the appointment of biotech veteran Dr. Lynn Seely to the board, and Benchmark’s upgrade to a Buy with an $11 price target are positive developments, but they don’t change the company’s long-term investment thesis.
The real reason investors are watching AbCellera is its AI-powered antibody discovery platform. Rather than depending ...
Most of the latest news has already been priced in. The earnings date announcement, the appointment of biotech veteran Dr. Lynn Seely to the board, and Benchmark’s upgrade to a Buy with an $11 price target are positive developments, but they don’t change the company’s long-term investment thesis.
The real reason investors are watching AbCellera is its AI-powered antibody discovery platform. Rather than depending ...
3
$AbCellera Biologics (ABCL.US)$ Cant buy enough! recently added to Russell 2000 index. 20 dolars by September!
2
$AbCellera Biologics (ABCL.US)$ All in at $7.50
3
1
$AbCellera Biologics (ABCL.US)$ $Jazz Pharmaceuticals (JAZZ.US)$ Jazz Pharma And AbCellera Announce Preclinical Research Collaboration, Option And License Agreement To Discover, Develop Next-Gen T-Cell Engaging Multispecific Antibodies
Benzinga
1m
The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any program Jazz exercises its option to develop
Jazz has the exclusive option to develop and commercia...
Benzinga
1m
The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any program Jazz exercises its option to develop
Jazz has the exclusive option to develop and commercia...
4
$AbCellera Biologics (ABCL.US)$
sorry i previously made a comment on the wrong stock thread please disregard i apologise
sorry i previously made a comment on the wrong stock thread please disregard i apologise
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)